Surrozen
Biotechnology Research • 
South San Francisco, California, United States • 51-100 Employees
Company overview
| Headquarters | 171 Oyster Point Blvd, South San Francisco, California 94080, US |
| Phone number | +16504899000 |
| Website | |
| SIC | 873 |
| Keywords | Regenerative Medicine, Liver Failure, Tissue Repair, Wnt Pathway |
| Employees | 51-100 |
| Socials |
Key Contacts at Surrozen
Shao Lin
Independent Board Director
Kimberly Guardado
Associate Director Of Benefits & Operations
Wan-Jung Lin
Director Of Finance
Russell Fletcher
Associate Director
Chenggang Lu
Director, Head Of Discovery Biology
Jay Villaluna
Associate Director, It Infrastructure And Operations
Pedro Gittens
Sr. Director, Quality Assurance
Esther Jhun
Exec. Director Of Finance And Controller
Pam Carper
Director Of It Infrastructure And Operations
Hui Chen
Associate Director
Surrozen Email Formats
Surrozen uses 5 email formats. The most common is {first initial} (e.g., j@surrozen.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@surrozen.com | 80% |
{first name} | john@surrozen.com | 10% |
{first initial}.{last name} | j.doe@surrozen.com | 2.5% |
{first name}.{last name} | john.doe@surrozen.com | 2.5% |
{first name}{last name} | johndoe@surrozen.com | 2.5% |
About Surrozen
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm. We are currently seeking highly creative scientists to join our team, and invite you to explore career opportunities on our website.
Surrozen revenue & valuation
| Annual revenue | $12,700,000 |
| Revenue per employee | $173,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $40,400,000 |
| Total funding | $312,500,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Surrozen has 25 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Surrozen's funding history, including investment rounds, total capital raised, and key backers.
Surrozen Tech Stack
Discover the technologies and tools that power Surrozen's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Hosting
Webmail
Miscellaneous
Security
Miscellaneous
Page builders
JavaScript libraries
JavaScript libraries
Miscellaneous
Australia
Frequently asked questions
4.8
40,000 users
